Nanoparticle-based model of anti-inflammatory drug releasing LbL coatings for uncemented prosthesis aseptic loosening prevention

References

• UK national joint registry 15th annual report [press release]; 2018.
   Google Scholar
• Aprato A, Risitano S, Sabatini L, Giachino M, Agati G, Massè A. Cementless total knee arthroplasty. Ann Transl Med Epidemiol. 2016;4(7):129. doi:10.21037/atm.2016.01.34
   Google Scholar
• Donaldson AJ, Thomson HE, Harper NJ, Kenny NW. Bone cement implantation syndrome. Br J Anaesth. 2009;102(1):12–22. doi:10.1093/bja/aen32819059919
   PubMed Web of Science ®Google Scholar
• Maggs J, Wilson M. The relative merits of cemented and uncemented prostheses in total hip arthroplasty. Indian J Orthop. 2017;51(4):377–385. doi:10.4103/ortho.IJOrtho_405_1628790466
   PubMedGoogle Scholar
• Landgraeber S, Jäger M, Jacobs JJ, Hallab NJ. The pathology of orthopedic implant failure is mediated by innate immune system cytokines. Mediators Inflamm. 2014;2014:9. doi:10.1155/2014/185150
   Web of Science ®Google Scholar
• Ulrich SD, Seyler TM, Bennett D, et al. Total hip arthroplasties: what are the reasons for revision? Int Orthop. 2008;32(5):597–604. doi:10.1007/s00264-007-0364-317443324
   PubMed Web of Science ®Google Scholar
• Rozkydal Z, Janik P, Janicek P, Kunovsky R. [Revision knee arthroplasty due to aseptic loosening]. Acta Chir Orthop Traumatol Cech. 2007;74(1):5–13.17331449
   PubMed Web of Science ®Google Scholar
• Goriainov V, Cook RB, Latham J, Dunlop D, Oreffo R. Bone and metal - an orthopaedic perspective on osseointegration of metals. Acta Biomater 2014;10(10):4043–4057. doi: 10.1016/j.actbio.2014.06.004
   Google Scholar
• Wu K, Chen YC, Hsu YM, Chang CH. Enhancing drug release from antibiotic-loaded bone cement using porogens. J Am Acad Orthop Surg. 2016;24(3):188–195. doi:10.5435/JAAOS-D-15-0046926855118
   PubMedGoogle Scholar
• Li D, Guo G, Fan R, et al. PLA/F68/dexamethasone implants prepared by hot-melt extrusion for controlled release of anti-inflammatory drug to implantable medical devices: I. Preparation, characterization and hydrolytic degradation study. Int J Pharm. 2013;441(1–2):365–372. doi:10.1016/j.ijpharm.2012.11.01923178216
   PubMedGoogle Scholar
• National Institute Clinical Excellence. Total hip replacement and resurfacing arthroplasty for end-stage arthritis of the hip. Technology appraisal guidance [TA304]; 2014.
   Google Scholar
• Boehler RM, Graham JG, Shea LD. Tissue engineering tools for modulation of the immune response. BioTechniques. 2011;51(4):239–passim. doi:10.2144/00011375421988690
   PubMed Web of Science ®Google Scholar
• Dumont CM, Park J, Shea LD. Controlled release strategies for modulating immune responses to promote tissue regeneration. J Control Release. 2015;219:155–166. doi:10.1016/j.jconrel.2015.08.01426264833
   PubMedGoogle Scholar
• Dang TT, Bratlie KM, Bogatyrev SR, Chen XY, Langer R, Anderson DG. Spatiotemporal effects of a controlled-release anti-inflammatory drug on the cellular dynamics of host response. Biomaterials. 2011;32(19):4464–4470. doi:10.1016/j.biomaterials.2011.02.04821429573
   PubMedGoogle Scholar
• Hickey T, Kreutzer D, Burgess DJ, Moussy F. Dexamethasone/PLGA microspheres for continuous delivery of an anti-inflammatory drug for implantable medical devices. Biomaterials. 2002;23(7):1649–1656. doi:10.1016/s0142-9612(01)00291-511922468
   PubMed Web of Science ®Google Scholar
• Zhou G, Ma L, Jing J, Jiang H. A meta-analysis of dexamethasone for pain management in patients with total knee arthroplasty. Medicine. 2018;97(35):e11753. doi:10.1097/MD.000000000001175330170371
   PubMedGoogle Scholar
• Tsurufuji S, Kurihara A, Ojima F. Mechanisms of anti-inflammatory action of dexamethasone: blockade by hydrocortisone mesylate and actinomycin D of the inhibitory effect of dexamethasone on leukocyte infiltration in inflammatory sites. J Pharmacol Exp Ther. 1984;229(1):237–243.6707940
   PubMed Web of Science ®Google Scholar
• Chuang HF, Smith RC, Hammond PT. Polyelectrolyte multilayers for tunable release of antibiotics. Biomacromolecules. 2008;9(6):1660–1668. doi:10.1021/bm800185h18476743
   PubMedGoogle Scholar
• Hammond PT. Building biomedical materials layer-by-layer. Mater Today. 2012;15(5):196–206. doi:10.1016/S1369-7021(12)70090-1
   Web of Science ®Google Scholar
• Macdonald ML, Samuel RE, Shah NJ, Padera RF, Beben YM, Hammond PT. Tissue integration of growth factor-eluting layer-by-layer polyelectrolyte multilayer coated implants. Biomaterials. 2011;32(5):1446–1453. doi:10.1016/j.biomaterials.2010.10.05221084117
   PubMed Web of Science ®Google Scholar
• Smith RC, Riollano M, Leung A, Hammond PT. Layer-by-layer platform technology for small-molecule delivery. Angew Chem Int Ed Engl. 2009;48(47):8974–8977. doi:10.1002/anie.20090278219847838
   PubMed Web of Science ®Google Scholar
• Wong SY, Moskowitz JS, Veselinovic J, et al. Dual functional polyelectrolyte multilayer coatings for implants: permanent microbicidal base with controlled release of therapeutic agents. J Am Chem Soc. 2010;132(50):17840–17848. doi:10.1021/ja106288c21105659
   PubMedGoogle Scholar
• Al Thaher Y, Perni S, Prokopovich P. Nano-carrier based drug delivery systems for sustained antimicrobial agent release from orthopaedic cementous material. Adv Colloid Interface Sci. 2017;249:234–247. doi:10.1016/j.cis.2017.04.01728477865
   PubMedGoogle Scholar
• Al Thaher Y, Yang L, Jones SA, Perni S, Prokopovich P, Xu B. LbL-assembled gentamicin delivery system for PMMA bone cements to prolong antimicrobial activity. PLoS One. 2018;13(12):e0207753. doi:10.1371/journal.pone.020775330543660
   PubMedGoogle Scholar
• Rivera MC, Perni S, Sloan A, Prokopovich P. Anti-inflammatory drug-eluting implant model system to prevent wear particle-induced periprosthetic osteolysis. Int J Nanomedicine. 2019;14:1069–1084. doi:10.2147/IJN.S18819330804671
   PubMedGoogle Scholar
• Lynn DM, Langer R. Degradable poly(β-amino esters): synthesis, characterization, and self-assembly with plasmid DNA. J Am Chem Soc. 2000;122(44):10761–10768. doi:10.1021/ja0015388
   Web of Science ®Google Scholar
• Al Thaher Y, Latanza S, Perni S, Prokopovich P. Role of poly-beta-amino-esters hydrolysis and electrostatic attraction in gentamicin release from layer-by-layer coatings. J Colloid Interface Sci. 2018;526:35–42. doi:10.1016/j.jcis.2018.04.04229715613
   PubMedGoogle Scholar
• Wall IB, Moseley R, Baird DM, et al. Fibroblast dysfunction is a key factor in the non-healing of chronic venous leg ulcers. J Invest Dermatol. 2008;128(10):2526–2540. doi:10.1038/jid.2008.11418449211
   PubMed Web of Science ®Google Scholar
• Perni S, Yang L, Preedy EC, Prokopovich P. Cobalt and titanium nanoparticles influence on human osteoblast mitochondrial activity and biophysical properties of their cytoskeleton. J Colloid Interface Sci. 2018;531:410–420. doi:10.1016/j.jcis.2018.07.02830048889
   PubMed Web of Science ®Google Scholar
• Mai TB, Tran TN, Rafiqul Islam M, Park JM, Lim KT. Covalent functionalization of silica nanoparticles with poly(N-isopropylacrylamide) employing thiol-ene chemistry and activator regenerated by electron transfer ATRP protocol. J Mater Sci. 2014;49(4):1519–1526. doi:10.1007/s10853-013-7833-4
   Web of Science ®Google Scholar
• Zhong G, Guo W, Liu Y, et al. Preparation of tetrasulfide-functionalized silica particles by hydrothermal assisted grafting method for removal of lead (II) via dynamic solid phase extraction. Colloids Surf A Physicochem Eng Asp. 2015;485(Complete):63–72. doi:10.1016/j.colsurfa.2015.09.006
   Google Scholar
• Du P, Zhao X, Zeng J, Guo J, Liu P. Layer-by-layer engineering fluorescent polyelectrolyte coated mesoporous silica nanoparticles as pH-sensitive nanocarriers for controlled release. Appl Surf Sci. 2015;345:90–98. doi:10.1016/j.apsusc.2015.03.151
   Web of Science ®Google Scholar
• Feng W, Nie W, He C, et al. Effect of pH-responsive alginate/chitosan multilayers coating on delivery efficiency, cellular uptake and biodistribution of mesoporous silica nanoparticles based nanocarriers. ACS Appl Mater Interfaces. 2014;6(11):8447–8460. doi:10.1021/am501337s24745551
   PubMed Web of Science ®Google Scholar
• Gosens I, Post JA, de la Fonteyne LJ, et al. Impact of agglomeration state of nano- and submicron sized gold particles on pulmonary inflammation. Part Fibre Toxicol. 2010;7(1):37. doi:10.1186/1743-8977-7-3721126342
   PubMedGoogle Scholar
• Gil-Tomás J, Tubby S, Parkin IP, et al. Lethal photosensitisation of staphylococcus aureus using a toluidine blue O–tiopronin–gold nanoparticle conjugate. J Mater Chem. 2007;17(35):3739–3746. doi:10.1039/b706615e
   Web of Science ®Google Scholar
• Goldie I, Nachemson A. Synovial pH in rheumatoid knee joints: II. The effect of local corticosteroid treatment. Acta Orthop Scand. 1970;41(3):354–362. doi:10.3109/174536770089915215486188
   PubMed Web of Science ®Google Scholar
• de Nadai TR, de Nadai MN, Albuquerque AA, de Carvalho MT, Celotto AC, Evora PR. Metabolic acidosis treatment as part of a strategy to curb inflammation. Int J Inflam. 2013;2013:601424. doi:10.1155/2013/60142423841017
   PubMedGoogle Scholar
• Shah NJ, Hyder MN, Moskowitz JS, et al. Surface-mediated bone tissue morphogenesis from tunable nanolayered implant coatings. Sci Transl Med. 2013;5(191):191ra183–191ra183. doi:10.1126/scitranslmed.3005576
   Web of Science ®Google Scholar
• Wang D, Miller SC, Liu X-M, Anderson B, Wang XS, Goldring SR. Novel dexamethasone-HPMA copolymer conjugate and its potential application in treatment of rheumatoid arthritis. Arthritis Res Ther. 2007;9(1):R2. doi:10.1186/ar210617233911
   PubMed Web of Science ®Google Scholar
• Anderson JM, Rodriguez A, Chang DT. Foreign body reaction to biomaterials. Semin Immunol. 2008;20(2):86–100. doi:10.1016/j.smim.2007.11.00418162407
   PubMed Web of Science ®Google Scholar
• Bridges AW, García AJ. Anti-inflammatory polymeric coatings for implantable biomaterials and devices. J Diabetes Sci Technol. 2008;2(6):984–994. doi:10.1177/19322968080020062819885288
   PubMedGoogle Scholar
• Vasconcelos DM, Ribeiro-da-Silva M, Mateus A, et al. Immune response and innervation signatures in aseptic hip implant loosening. J Transl Med. 2016;14(1):205. doi:10.1186/s12967-016-0950-527387445
   PubMedGoogle Scholar
• Jiranek WA, Machado M, Jasty M, et al. Production of cytokines around loosened cemented acetabular components. analysis with immunohistochemical techniques and in situ hybridization. J Bone Joint Surg Am. 1993;75(6):863–879. doi:10.2106/00004623-199306000-000078314826
   PubMed Web of Science ®Google Scholar
• Goldring SR, Schiller AL, Roelke M, Rourke CM, O’Neil DA, Harris WH. The synovial-like membrane at the bone-cement interface in loose total hip replacements and its proposed role in bone lysis. J Bone Joint Surg Am. 1983;65(5):575–584.6304106
   PubMed Web of Science ®Google Scholar
• Gu Q, Shi Q, Yang H. The role of TLR and chemokine in wear particle-induced aseptic loosening. J Biomed Biotechnol. 2012;2012:596870. doi:10.1155/2012/59687023193363
   PubMedGoogle Scholar
• Wolf Y, Shemer A, Polonsky M, et al. Autonomous TNF is critical for in vivo monocyte survival in steady state and inflammation. J Exp Med. 2017;214(4):905–917. doi:10.1084/jem.2016049928330904
   PubMedGoogle Scholar
• Glue C, Hansen JB, Schjerling P, Jinquan T, Poulsen LK. LPS-induced cytokine production in the monocytic cell line THP-1 determined by multiple quantitative competitive PCR (QC-PCR). Scand J Clin Lab Invest. 2002;62(6):405–412.12469895
   PubMed Web of Science ®Google Scholar
• Moreira-Tabaka H, Peluso J, Vonesch J-L, et al. Unlike for human monocytes after LPS activation, release of TNF-α by THP-1 cells is produced by a TACE catalytically different from constitutive TACE. PLoS One. 2012;7(3):e34184. doi:10.1371/journal.pone.003418422479555
   PubMedGoogle Scholar
• Qin Z. The use of THP-1 cells as a model for mimicking the function and regulation of monocytes and macrophages in the vasculature. Atherosclerosis. 2012;221(1):2–11. doi:10.1016/j.atherosclerosis.2011.09.00321978918
   PubMed Web of Science ®Google Scholar
• Cochran FR, Finch-Arietta MB. Interleukin-6 can prime THP-1 macrophages for enhanced production of tumor necrosis factor-alpha in response to LPS. Immunopharmacology. 1992;23(2):97–103.1601643
   PubMedGoogle Scholar
• Liu D-Q, Li L-M, Guo Y-L, et al. Signal regulatory protein α negatively regulates β2 integrin-mediated monocyte adhesion, transendothelial migration and phagocytosis. PLoS One. 2008;3(9):e3291. doi:10.1371/journal.pone.000329118820737
   PubMedGoogle Scholar
• Dale DC, Boxer L, Liles WC. The phagocytes: neutrophils and monocytes. Blood. 2008;112(4):935–945. doi:10.1182/blood-2007-12-07791718684880
   PubMed Web of Science ®Google Scholar
• Mikulewicz M, Chojnacka K. Cytocompatibility of medical biomaterials containing nickel by osteoblasts: a systematic literature review. Biol Trace Elem Res. 2011;142(3):865–889. doi:10.1007/s12011-010-8798-720703824
   PubMedGoogle Scholar
• Baranowski A, Klein A, Ritz U, et al. Surface functionalization of orthopedic titanium implants with bone sialoprotein. PLoS One. 2016;11(4):e0153978. doi:10.1371/journal.pone.015397827111551
   PubMedGoogle Scholar
• Chaffey N, Alberts B, Johnson A, et al. Molecular biology of the cell. 4th edn. Ann Bot. 2003;91(3):401. doi:10.1093/aob/mcg023
   Google Scholar